Background/Aim: Breast cancer treatment mainly involves interventional methods such as surgical resection and chemotherapy. How to best perform these treatments during the COVID-19 pandemic remains to be established. Patients and Methods: Patients with breast cancer who received SARS-CoV-2 PCR screening before cancer treatment from December 2020 to April 2021 were included. PCR screening was performed within 72 hours of the scheduled admission time and treatment. Results: A total of 19 tests in 15 patients were analysed. Fourteen cases displayed no symptoms, and five cases had some symptoms. COVID PCR tests were negative in all cases. Conclusion: COVID-19 screening can ensure that breast cancer patients do not miss scheduled treatments as a result of the pandemic. Diagnosis of patients with symptoms that are shared by COVID-19 infection, chemotherapy, and breast cancer recurrence must be performed carefully. Copyright 2021, International Institute of Anticancer Research.
Background/Aim: Breast cancer treatment mainly involves interventional methods such as surgical resection and chemotherapy. How to best perform these treatments during the COVID-19 pandemic remains to be established. Patients and Methods: Patients with breast cancer who received SARS-CoV-2 PCR screening before cancer treatment from December 2020 to April 2021 were included. PCR screening was performed within 72 hours of the scheduled admission time and treatment. Results: A total of 19 tests in 15 patients were analysed. Fourteen cases displayed no symptoms, and five cases had some symptoms. COVID PCR tests were negative in all cases. Conclusion: COVID-19 screening can ensure that breast cancer patients do not miss scheduled treatments as a result of the pandemic. Diagnosis of patients with symptoms that are shared by COVID-19 infection, chemotherapy, and breast cancer recurrence must be performed carefully. Copyright 2021, International Institute of Anticancer Research.
Authors: Evandro de Azambuja; Dario Trapani; Sibylle Loibl; Suzette Delaloge; Elzbieta Senkus; Carmen Criscitiello; Philip Poortman; Michael Gnant; Serena Di Cosimo; Javier Cortes; Fatima Cardoso; Shani Paluch-Shimon; Giuseppe Curigliano Journal: ESMO Open Date: 2020-05
Authors: Humaid O Al-Shamsi; Waleed Alhazzani; Ahmad Alhuraiji; Eric A Coomes; Roy F Chemaly; Meshari Almuhanna; Robert A Wolff; Nuhad K Ibrahim; Melvin L K Chua; Sebastien J Hotte; Brandon M Meyers; Tarek Elfiki; Giuseppe Curigliano; Cathy Eng; Axel Grothey; Conghua Xie Journal: Oncologist Date: 2020-04-27
Authors: Jill R Dietz; Meena S Moran; Steven J Isakoff; Scott H Kurtzman; Shawna C Willey; Harold J Burstein; Richard J Bleicher; Janice A Lyons; Terry Sarantou; Paul L Baron; Randy E Stevens; Susan K Boolbol; Benjamin O Anderson; Lawrence N Shulman; William J Gradishar; Debra L Monticciolo; Donna M Plecha; Heidi Nelson; Katharine A Yao Journal: Breast Cancer Res Treat Date: 2020-04-24 Impact factor: 4.872